Join David Thomas from the International Rare Cancers Initiative at 9am GMT on 14 December to hear more about the Molecular Screening and Therapeutics study.
This study aims to improve access for targeted treatments to people affected by rare cancers through genomic profiling.
David will share his experiences of developing working relationships with pharmaceutical companies and outline different models of interaction between clinical research teams, government, pharma, patient advocates and the public.